# Tamsulosin Dose Escalation or Silodosin Switch Before Trial Without Catheter in BPH-Related Acute Urinary Retention

> **NCT07650968** · PHASE4 · RECRUITING · sponsor: **Beni-Suef University** · enrollment: 378 (estimated)

## Conditions studied

- Acute Urinary Retention
- Benign Prostatic Hyperplasia

## Interventions

- **DRUG:** Tamsulosin 0.4 mg
- **DRUG:** Tamsulosin 0.8 mg
- **DRUG:** Silodosin 8 mg

## Key facts

- **NCT ID:** NCT07650968
- **Lead sponsor:** Beni-Suef University
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2026-06-08
- **Primary completion:** 2027-05
- **Final completion:** 2027-06
- **Target enrollment:** 378 (ESTIMATED)
- **Last updated:** 2026-06-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07650968

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07650968, "Tamsulosin Dose Escalation or Silodosin Switch Before Trial Without Catheter in BPH-Related Acute Urinary Retention". Retrieved via MORVS 2026-10-20 from https://api.morvs.ai/clinical/NCT07650968. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*